Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141557 · ClinicalTrials.gov registry record · Phase 2
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
A Phase 2 study, sponsored by Solvay Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 133
- Enrollment target
NCT00141557 is a Phase 2 study that was terminated before completion, run by Solvay Pharmaceuticals. The registered enrollment target is 133 participants.
The verdict
NCT00141557, a Phase 2 study, was terminated before completion, sponsored by Solvay Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 133 participants
- Enrollment target
Study Summary
To determine whether treatment with ESTRATEST® Tablets is superior to treatment with esterified estrogens tablets
Interventions
- DRUG esterified estrogens 1.25mg and methyltestosterone 2.5mg
- DRUG Esterified estrogens 1.25 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00141557
The ClinicalTrials.gov registry entry for NCT00141557 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solvay Pharmaceuticals, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which esterified estrogens 1.25mg and methyltestosterone 2.5mg is the first listed.
NCT00141557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00141557 about?
NCT00141557 is a clinical study titled "The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women". To determine whether treatment with ESTRATEST® Tablets is superior to treatment with esterified estrogens tablets
What is the current status of trial NCT00141557?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 133 participants. The study started on 2004-07. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00141557?
The interventions under investigation include: esterified estrogens 1.25mg and methyltestosterone 2.5mg (DRUG), Esterified estrogens 1.25 mg (DRUG).
Who is sponsoring clinical trial NCT00141557?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.